Cell and extracellular vesicle therapies for AKI in critical care: clinical translation, organ-support integration, and lessons learned

• by Amankeldi A. Salybekov, Aiman Kinzhebay, Aina Zhanymbetova, Shuzo Kobayashi

• July 9, 2026

Exploring the relationship between novel serum inflammatory markers, non-traditional lipid parameters, and in-stent restenosis after percutaneous coronary intervention: a single-center retrospective study

• by Mingliang Du, Miao Jiang, Hui Hui

• July 9, 2026

Do Systemic Alpha-2 Agonists Lower Glaucoma Risk?

A large US cohort study found systemic alpha-2 agonist use was associated with a lower hazard of glaucoma-related diagnoses vs. beta-blockers.

• by Andrea Surnit

• July 8, 2026

• 3 min

Temporal trends and projected mortality of myocardial infarction and heart failure in the United States, 1999–2035: a CDC WONDER analysis

• by Muhammad Hussain Azam, Muhammad Hassan Azam, Divesh Sunil Sachdev, Hasibullah Aminpoor, Taha Ahmed, Talha Aamir, Muhammad Tayyab Azam, Nazila Dalir, Faizan Ahmed

• July 9, 2026